Imodium Instant Smelttablet

Loperamide, the active ingredient in Imodium Instant Smelttablet, is an antidiarrheal presented as an oral disintegrating tablet for oral use. It treats acute nonspecific diarrhea and chronic diarrhea associated with inflammatory bowel disease in adults.

GNH USA supplies Imodium Instant Smelttablet as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium Instant Smelttablet contains loperamide, an antidiarrheal that acts on the gastrointestinal tract to reduce stool frequency and improve consistency.

Acute nonspecific diarrhea: reduces stool output and restores normal consistency. Chronic diarrhea associated with inflammatory bowel disease: helps control symptoms and decrease urgency. Travelers' diarrhea: provides symptomatic relief by slowing intestinal transit.

Loperamide is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Constipation - Abdominal cramping - Nausea - Dizziness

Serious or Rare Side Effects: - Severe constipation leading to bowel obstruction - Toxic megacolon - Allergic reactions such as rash or facial swelling - Cardiac arrhythmias, including QT prolongation

Use Imodium Instant Smelttablet with caution and follow prescriber guidance.

Do not use in patients with known hypersensitivity to loperamide. Avoid use in active bacterial enterocolitis or pseudomembranous colitis. Use cautiously in patients with hepatic impairment. Do not exceed the recommended dose; adhere to prescriber instructions. Store at ambient temperature: keep in the original pack, protect from moisture.

Loperamide may interact with other medicines; some combinations require avoidance, others close monitoring.

Major Interactions (Avoid): - Concomitant potent CYP3A4 inhibitors (e.g., ketoconazole) may raise loperamide levels. - Use with other antidiarrheals (e.g., diphenoxylate) can cause additive constipation. - Co‑administration with opioids that affect gut motility increases risk of severe constipation.

Moderate Interactions (Monitor Closely): - Quinidine may alter cardiac conduction when combined with loperamide. - Drugs that prolong QT interval (e.g., macrolide antibiotics) may increase arrhythmia risk. - Anticholinergic agents may enhance dry‑mouth effects. - Certain antifungal agents may modestly increase plasma concentrations.